JAC Advance Access originally published online on December 9, 2005
Journal of Antimicrobial Chemotherapy 2006 57(2):266-272; doi:10.1093/jac/dki447
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters
Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3TL, Wales, UK
Received 24 May 2005; returned 4 September 2005; revised 5 October 2005; accepted 12 November 2005
* Corresponding author. Tel: +44-29-20874311; Fax: +44-29-20874305; E-mail: stickler{at}cardiff.ac.uk
Objectives: To examine (i) the effect of triclosan on the formation of catheter biofilms by urinary tract pathogens and (ii) the diffusion of triclosan through the retention balloons of urinary catheters.
Methods: Models of the catheterized bladder were infected with eight different urinary tract pathogens and the effect of triclosan on biofilm formation was assessed by determining the numbers of viable cells colonizing the catheters and by scanning electron microscopy. HPLC was used to determine the triclosan concentration in urine draining from models that had been fitted with triclosan-inflated silicone catheters.
Results: When catheters were inflated with triclosan (10 g/L) the formation of catheter biofilm by Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Proteus mirabilis was prevented. The numbers of Enterococcus faecalis and Providencia stuartii cells colonizing catheters were also significantly reduced (P < 0.05). Serratia marcescens, Morganella morganii and Pseudomonas aeruginosa, however, were able to produce extensive catheter biofilms in the presence of triclosan. Only P. mirabilis produced alkaline urine and encrusted the catheters. Concentrations of 0.020.16 mg/L of the biocide were detected in urine draining from the model over the 48 h experimental period.
Conclusions: Triclosan diffused through silicone catheter balloons and produced urinary concentrations that prevented catheter encrustation by P. mirabilis and biofilm formation by several other common pathogens of the catheterized urinary tract. It had little effect on urease-producing P. aeruginosa, S. marcescens or M. morganii but these species did not produce alkaline urine or crystalline biofilms.
Keywords: urinary tract infections , Proteus mirabilis , antibacterials , uropathogenic strains
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. O. Darouiche, M. D. Mansouri, P. V. Gawande, and S. Madhyastha Antimicrobial and antibiofilm efficacy of triclosan and DispersinB(R) combination J. Antimicrob. Chemother., July 1, 2009; 64(1): 88 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. O'May, S. M. Jacobsen, M. Longwell, P. Stoodley, H. L. T. Mobley, and M. E. Shirtliff The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation Microbiology, May 1, 2009; 155(5): 1523 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Williams and D. J. Stickler Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters J. Med. Microbiol., September 1, 2008; 57(9): 1135 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kalivoda, N. A. Stella, D. M. O'Dee, G. J. Nau, and R. M. Q. Shanks The Cyclic AMP-Dependent Catabolite Repression System of Serratia marcescens Mediates Biofilm Formation through Regulation of Type 1 Fimbriae Appl. Envir. Microbiol., June 1, 2008; 74(11): 3461 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stickler and G. L. Jones Reduced Susceptibility of Proteus mirabilis to Triclosan Antimicrob. Agents Chemother., March 1, 2008; 52(3): 991 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, E. C. Weiss, M. Otto, P. D. Fey, M. S. Smeltzer, and G. A. Somerville Staphylococcus aureus Biofilm Metabolism and the Influence of Arginine on Polysaccharide Intercellular Adhesin Synthesis, Biofilm Formation, and Pathogenesis Infect. Immun., September 1, 2007; 75(9): 4219 - 4226. [Abstract] [Full Text] [PDF] |
||||





